Table 3 |
|||||||||
|
Frequency of Use of Pain Medications |
|||||||||
| Pain Medications |
Diabetes (N = 55,972) |
Diabetic Neuropathy (N = 2,146) |
Diabetes and Depression (N = 2,379) |
P-Value |
|||||
|
|
|||||||||
| N |
% |
N |
% |
N |
% |
DM v DN |
DM v DD |
DN v DD |
|
|
|
|||||||||
| Antidepressants |
|||||||||
| SSRI |
3,376 |
6.03 |
536 |
24.98 |
1,346 |
56.58 |
* |
* |
* |
| Tricyclic |
1,884 |
3.37 |
366 |
17.05 |
354 |
14.88 |
* |
* |
** |
| Venlafaxine |
271 |
0.48 |
58 |
2.70 |
216 |
9.08 |
* |
* |
* |
| Bupropion |
750 |
1.34 |
109 |
5.08 |
333 |
14.00 |
* |
* |
* |
| Other Antidepressant |
641 |
1.15 |
127 |
5.92 |
414 |
17.40 |
* |
* |
* |
| Any Antidepressant |
5,979 |
10.68 |
887 |
41.33 |
1,715 |
72.09 |
* |
* |
* |
| Anticonvulsant |
|||||||||
| Gabapentin |
867 |
1.55 |
286 |
13.33 |
197 |
8.28 |
* |
* |
* |
| Other Anticonvulsant |
911 |
1.63 |
137 |
6.38 |
273 |
11.48 |
* |
* |
* |
| Any Anticonvulsant |
1,669 |
2.98 |
388 |
18.08 |
414 |
17.40 |
* |
* |
0.4693 |
| Skeletal-Muscle Relaxants |
3,623 |
6.47 |
349 |
16.26 |
404 |
16.98 |
* |
* |
0.6165 |
| Non-Narcotics |
1,018 |
1.82 |
88 |
4.10 |
134 |
5.63 |
* |
* |
** |
| Narcotics |
|||||||||
| Oxycodone |
2,789 |
4.98 |
370 |
17.24 |
353 |
14.84 |
* |
* |
*** |
| Tramadol |
1,043 |
1.86 |
129 |
6.01 |
144 |
6.05 |
* |
* |
0.9949 |
| Codeine |
3,128 |
5.59 |
300 |
13.98 |
306 |
12.86 |
* |
* |
0.2611 |
| Hydrocodone-Acetaminophen |
5,545 |
9.91 |
528 |
24.60 |
645 |
27.11 |
* |
* |
*** |
| Proxyphene |
3,374 |
6.03 |
350 |
16.31 |
369 |
15.51 |
* |
* |
0.5303 |
| Other Narcotics |
1,051 |
1.88 |
121 |
5.64 |
150 |
6.31 |
* |
* |
0.2740 |
| Any Narcotics |
12,383 |
22.12 |
1,065 |
44.63 |
1,152 |
48.42 |
* |
* |
0.6036 |
| NSAIDs |
|||||||||
| Cox-2 |
4,445 |
7.94 |
355 |
16.54 |
407 |
17.11 |
* |
* |
0.7753 |
| Other NSAID |
10,005 |
17.88 |
761 |
35.46 |
823 |
34.59 |
* |
* |
0.7367 |
| Any NSAID |
12,839 |
22.94 |
938 |
43.71 |
1,040 |
43.72 |
* |
* |
1.00 |
|
|
|||||||||
|
*P-value ≤ 0.0001; **P-value ≤ 0.001; ***P-value ≤ 0.05 P values based on Tukey-Kramer method to adjust for multiple comparisons. |
|||||||||
|
Le et al. Cost Effectiveness and Resource Allocation 2006 4:18 doi:10.1186/1478-7547-4-18 |
|||||||||